Mean demographic and clinical data in 233 patients with Parkinson’s disease
Age (y) | 73.6 (8.4) |
---|---|
Sex (% female) | 51 |
Living alone (%) | 39.2 |
MADRS total score | 8.0 (6.2) |
Major depression (DSM III R) | 7.7% |
MMSE total score | 24.4 (6.9) |
Nocturnal sleep disturbances (%) | 60.3 |
Duration of disease (y) | 6.3 (5.3) |
Daily levodopa dose (mg) | 496 (233) |
Side mostly affected (%): | |
Left | 38.9 |
Right | 50.0 |
Symmetric | 11.1 |
Parkinson type (%): | |
Tremor | 11.4 |
Akinetic | 20.4 |
Mixed | 68.2 |
UPDRS: | |
Total score | 49.3 (26.2) |
Part 1 score | 3.8 (2.8) |
Part 2 score | 14.6 (8.9) |
Part 3 score | 28.4 (15.8) |
Part 4 score | 2.7 (3.3) |
Hoehn and Yahr stage | 2.9 (1.1) |
Schwab and England score | 67.5 (23.7) |
Tremor score | 3.5 (3.4) |
Postural abnormalities score | 3.0 (1.9) |
Rigidity score | 3.7 (3.3) |
Akinesia score | 11.0 (6.5) |
Dyskinesias (%) | 22.9 |
Motor fluctuations (%) | 20.4 |
Values in parenthes are SD.